New study aims to unlock secrets of immune tolerance in hemophilia a kids
NCT ID NCT07539402
First seen May 02, 2026 · Last updated May 05, 2026 · Updated 1 time
Summary
This study looks at how children with hemophilia A (a bleeding disorder) keep their immune system from attacking the clotting medicine they need. Researchers will follow 500 children under 18 who use a newer type of preventive treatment called non-factor therapy. By taking blood and stool samples over time, they hope to learn why some children develop antibodies that block treatment while others do not. This is an observational study, meaning no new treatments are tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC, locatie AMC
Amsterdam, North Holland, 1105AZ, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.